Navigation Links
Golden Meditech Announces Plan to Issue Taiwan Depository Receipts

Golden Meditech Announces Plan to Issue Taiwan Depository Receipts -- HONG KONG, Aug. 31 /PRNewswire-Asia-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Stock Offering Click to view news release full screen  

Golden Meditech Announces Plan to Issue Taiwan Depository Receipts


Reaping the Fruit of Economic Cooperation Framework Agreement

HONG KONG, Aug. 31 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," 801.HK), China's leading integrated healthcare enterprise, is pleased to announce that the Group is considering to list its shares on the Taiwan Stock Exchange through the issuance of Taiwan Depositary Receipts ("TDRs"), and has appointed Polaris Securities Co., Ltd. as the financial advisor for the proposed listing. The Group will become the first integrated healthcare company listed on Taiwan's stock market should the company proceed with the proposed TDR issuance upon obtaining relevant regulatory approval.

Mr. Kam Yuen, Chairman and Chief Executive Officer of the Group said that China's ongoing medical reform and the newly launched preferential trade agreement under Economic Cooperation Framework Agreement ("ECFA") has created a perfect window to encourage stronger strategic collaborations between Taiwan and China, amongst which, the sharing of corporate and human resources, etc.

Mr. Kam said that Taiwan's well developed healthcare insurance system as well as its world-class healthcare corporations can help to strengthen the Group's existing medical devices and healthcare services businesses in China. Citing closer collaborations between Taiwan and China which opens up numerous investment opportunities, the Group would like to leverage this opportunity to strengthen and speed up its business development initiatives, including knowledge-sharing of Taiwan's experience in the development of its healthcare industries, with similar attributes to China's development in many ways.

Based on the track records of other TDR issuances, Mr. Kam is confident that the Group will be able to enhance the liquidity of its shares while broadening its shareholder base, and enable quality investors from Taiwan to invest in Group's shares while promote the Group's corporate image in Taiwan.

About Golden Meditech Holdings Limited

Golden Meditech Holdings Limited is China's leading integrated-healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx). Thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities Golden Meditech has, over the years, established itself as a first-mover in China's healthcare industry with dominant positions in medical devices and healthcare services markets. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For enquiries, please contact: Golding Meditech Holdings Limited Investor Relations Department Add: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong Tel: +852-3605-8180 Fax: +852-3605-8181 Email:

SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech Announces Annual Results for FY 2009/10
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... ) has announced the addition of ... Testing Market: Campylobacter, Cryptosporidium, E. Coli, ... Yersinia" report to their offering. ... announced the addition of the ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... --  Craneware, Inc ., the healthcare market leader ... company will showcase a new version of its ... at the American Society for Health-System Pharmacists (ASHP) ... features are focused on simplifying and streamlining the ... pharmacy charges to ensure compliance and optimal revenue ...
Breaking Medicine Technology:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- ... of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays ... film for accurate interpretation by the radiologist. The marking utensils are so small, ... Calif., has found a way to alleviate this problem. , He developed the ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... Burlington, MA (PRWEB) , ... December 01, 2015 , ... ... the release of Clarity, the latest addition to the devices for sale in the ... technologies, 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - CES, Las Vegas, ... Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, where they will ... Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among ...
Breaking Medicine News(10 mins):